Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Neurotraumatic Surgery(Electronic Edition) ›› 2026, Vol. 12 ›› Issue (03): 173-179. doi: 10.3877/cma.j.issn.2095-9141.2026.03.005

• Clinical Research • Previous Articles    

Analysis of the diagnostic value of serum ox-LDL, caveolin-1, Nogo-A for postoperative cerebral edema in patients with acute cerebral hemorrhage before minimally invasive interventional hematoma removal

Yongjun Zhu(), Dong Zhang, Dewen Hou   

  1. Department of Neurosurgery, Suining Hospital of Traditional Chinese Medicine, Suining 629000, China
  • Received:2025-03-07 Online:2026-06-15 Published:2026-08-20
  • Contact: Yongjun Zhu

Abstract:

Objective

To investigate the diagonstic value of oxo-modified low-density lipoprotein (ox-LDL), caveolin-1, and serum axon growth inhibitory factor (Nogo-A) and postoperative cerebral edema in patients with acute cerebral hemorrhage before minimally invasive interventional hematoma removal.

Methods

A total of 105 patients with acute cerebral hemorrhage who received minimally invasive interventional hematoma removal at Suining Hospital of Traditional Chinese Medicine from January 2023 to January 2024 were selected and divided into cerebral edema group and non-cerebral edema group according to whether postoperative cerebral edema 48 h after the operation was complicated, and the general data, preoperative ox-LDL, caveolin-1 positive and Nogo-A levels of patients in the two groups were compared. Multivariate Logistic regression analysis was used to analyze the influencing factors of cerebral edema after minimally invasive interventional hematoma removal in patients with acute cerebral hemorrhage. The receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic efficacy of preoperative ox-LDL, caveolin-1, and Nogo-A levels for cerebral edema after minimally invasive interventional hematoma removal in patients with acute cerebral hemorrhage.

Results

Among the 105 patients included in the study, 35 cases developed cerebral edema after surgery (cerebral edema group), with an incidence of 33.33%, the remaining 70 cases were in non-cerebral edema group. The levels of ox-LDL, Nogo-A and the positive rate of caveolin-1 in cerebral edema group were higher than those in non-cerebral edema group, and the differences were statistically significant (P<0.05). Multivariate Logistic regression analysis showed that preoperative ox-LDL, caveolin-1 positivity, and Nogo-A were independent influencing factors for cerebral edema after minimally invasive interventional hematoma removal in patients with acute cerebral hemorrhage (P<0.05). ROC curve analysis showed that the cutoff values of ox-LDL and Nogo-A were 0.66 mg/L and 138.93 ng/mL, respectively. The AUC values for diagnosing cerebral edema after minimally invasive hematoma clearance in patients with acute cerebral hemorrhage were 0.893 (95%CI: 0.817-0.945) and 0.852 (95%CI: 0.770-0.914), respectively; the AUC of caveolin-1 positive diagnosis for cerebral edema after minimally invasive hematoma clearance in patients with acute cerebral hemorrhage was 0.657 (95%CI: 0.558-0.747); the AUC of the combined diagnosis of the three indicators was 0.950 (95%CI: 0.889-0.983), which was higher than the detection of each indicator separately, and the difference was statistically significant (P<0.05).

Conclusions

The levels of preoperative ox-LDL, caveolin-1 and Nogo-A are independent influencing factors for cerebral edema after minimally invasive interventional hematoma removal in patients with acute cerebral hemorrhage. The combined detection of the three indicators has better predictive efficacy for postoperative cerebral edema than the individual application of each indicator.

Key words: Acute cerebral hemorrhage, Minimally invasive hematoma removal surgery, Cerebral edema, Serum oxidation modified low density lipoprotein, caveolin-1, Serum axon growth inhibition factor, Influencing factor

京ICP 备07035254号-20
Copyright © Chinese Journal of Neurotraumatic Surgery(Electronic Edition), All Rights Reserved.
Tel: 010-64229160 E-mail: zhsjcswk2015@163.com
Powered by Beijing Magtech Co. Ltd